Bio-Rad Laboratories | BIO - Ordinary Share Capital


Bio-Rad Laboratories reported $26.74M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Agilent USD 281.97M 252K Jun/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Bruker USD 152.35M 130K Jun/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Danaher USD 703.4M 500K Sep/2026
General Electric Aerospace USD 1.03B 4.21M Sep/2026
Illumina USD 151.3M 607K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Laboratory Of America USD 80.9M 1.4M Jun/2026
Merck USD 2.47B 4.93M Mar/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quest Diagnostics USD 110M 0 Sep/2026
Repligen USD 56.43M 28K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Siemens EUR 762.74M 0 Jun/2026
Standard Biotools USD 390.14M 3.76M Mar/2026
Thermo Fisher Scientific USD 369.75M 1.88M Sep/2026
Tosoh JPY 307.89M 2K Jun/2026
Waters USD 98.19M 20K Jun/2026